Suppr超能文献

葡萄糖注射疗法与对照注射治疗疼痛性肩袖肌腱病的比较

Dextrose Prolotherapy Versus Control Injections in Painful Rotator Cuff Tendinopathy.

作者信息

Bertrand Helene, Reeves Kenneth Dean, Bennett Cameron J, Bicknell Simon, Cheng An-Lin

机构信息

Department of Family Practice, School of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Department of Physical Medicine and Rehabilitation, University of Kansas, Kansas City, KS.

出版信息

Arch Phys Med Rehabil. 2016 Jan;97(1):17-25. doi: 10.1016/j.apmr.2015.08.412. Epub 2015 Aug 22.

Abstract

OBJECTIVE

To compare the effect of dextrose prolotherapy on pain levels and degenerative changes in painful rotator cuff tendinopathy against 2 potentially active control injection procedures.

DESIGN

Randomized controlled trial, blinded to participants and evaluators.

SETTING

Outpatient pain medicine practice.

PARTICIPANTS

Persons (N=73) with chronic shoulder pain, examination findings of rotator cuff tendinopathy, and ultrasound-confirmed supraspinatus tendinosis/tear.

INTERVENTIONS

Three monthly injections either (1) onto painful entheses with dextrose (Enthesis-Dextrose), (2) onto entheses with saline (Enthesis-Saline), or (3) above entheses with saline (Superficial-Saline). All solutions included 0.1% lidocaine. All participants received concurrent programmed physical therapy.

MAIN OUTCOME MEASURES

Primary: participants achieving an improvement in maximal current shoulder pain ≥2.8 (twice the minimal clinically important difference for visual analog scale pain) or not. Secondary: improvement in the Ultrasound Shoulder Pathology Rating Scale (USPRS) and a 0-to-10 satisfaction score (10, completely satisfied).

RESULTS

The 73 participants had moderate to severe shoulder pain (7.0±2.0) for 7.6±9.6 years. There were no baseline differences between groups. Blinding was effective. At 9-month follow-up, 59% of Enthesis-Dextrose participants maintained ≥2.8 improvement in pain compared with Enthesis-Saline (37%; P=.088) and Superficial-Saline (27%; P=.017). Enthesis-Dextrose participants' satisfaction was 6.7±3.2 compared with Enthesis-Saline (4.7±4.1; P=.079) and Superficial-Saline (3.9±3.1; P=.003). USPRS findings were not different between groups (P=.734).

CONCLUSIONS

In participants with painful rotator cuff tendinopathy who receive physical therapy, injection of hypertonic dextrose on painful entheses resulted in superior long-term pain improvement and patient satisfaction compared with blinded saline injection over painful entheses, with intermediate results for entheses injection with saline. These differences could not be attributed to a regenerative effect. Dextrose prolotherapy may improve on the standard care of painful rotator cuff tendinopathy for certain patients.

摘要

目的

比较葡萄糖注射疗法与另外两种可能有效的对照注射程序对疼痛性肩袖肌腱病患者疼痛程度和退变改变的影响。

设计

随机对照试验,对参与者和评估者设盲。

地点

门诊疼痛医学诊所。

参与者

73例患有慢性肩部疼痛、经检查发现肩袖肌腱病且经超声证实有冈上肌腱病/撕裂的患者。

干预措施

每月注射一次,共注射三次,注射部位分别为:(1)疼痛的附着点处注射葡萄糖(附着点-葡萄糖组);(2)附着点处注射生理盐水(附着点-生理盐水组);(3)附着点上方注射生理盐水(浅表-生理盐水组)。所有溶液均含有0.1%利多卡因。所有参与者均接受同步的程序化物理治疗。

主要观察指标

主要指标:参与者最大当前肩部疼痛改善≥2.8(视觉模拟量表疼痛最小临床重要差异的两倍)与否。次要指标:超声肩部病理评分量表(USPRS)的改善情况以及0至10分的满意度评分(10分表示完全满意)。

结果

73例参与者有中度至重度肩部疼痛(7.0±2.0),疼痛时长7.6±9.6年。各组间基线无差异。设盲有效。在9个月随访时,附着点-葡萄糖组59%的参与者疼痛改善≥2.8,而附着点-生理盐水组为37%(P = 0.088),浅表-生理盐水组为27%(P = 0.017)。附着点-葡萄糖组参与者的满意度为6.7±3.2,附着点-生理盐水组为4.7±4.1(P = 0.079),浅表-生理盐水组为3.9±3.1(P = 0.003)。各组间USPRS结果无差异(P = 0.734)。

结论

在接受物理治疗的疼痛性肩袖肌腱病患者中,与在疼痛附着点处进行设盲生理盐水注射相比,在疼痛附着点处注射高渗葡萄糖可带来更好的长期疼痛改善和患者满意度,在附着点处注射生理盐水的效果居中。这些差异不能归因于再生效应。对于某些患者,葡萄糖注射疗法可能优于疼痛性肩袖肌腱病的标准治疗。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验